SlideShare a Scribd company logo
1 of 27
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 1
DISCLOSURES
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 2
• None
HISTORY OF PRESENT ILLNESS
• Chief complaint: New onset headache for 5 days
• History of present illness:
48 year old African American female with history of Hypothyroidism and Hypertension otherwise in
good health presented to the university ER with the new onset headache for the past 5 days which
is located on the Right temporal region and was about 10/10 in intensity, started slowly and
gradually progressed. Pain is throbbing with occasional sharp character over the right temple with
no radiation. Sleep and IBUPROFEN make the pain better and looking towards the right makes the
pain worse. No changes with position, coughing or bearing down, diurnal variations or with chewing.
The headache is also associated with light sensitivity and occasional sonophobia, Kinesophobia.
She also complained of double vision when looking to the right side associated with pain with the
false image on the outer side of the original image.
Her eyes have been red, right-sided greater than left side since the same day when the
headache started initially. Complained of gritty sensation, dryness.
Negative history: she denied any fever, chills, neck stiffness, passing out spells, lateralized
weakness or numbness. Denied any stress. No fatigue, dizziness, lightheadedness, loss of
appetite, weight or recent weight gain. No recent URI symptoms or dental infections.
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 3
HISTORY CONTINUED…
• PMH/PSH: Hypertension, Hypothyroidism S/p Thyroidectomy in 1981 for Grave’s Disease
• Family History: Father had MI and died of Stroke
• Paternal grandfather with Seizure, No family history of Migraines or AVMs
• Strong family history of Grave’s disease with affected Grand Mother, Mother and three
sisters
• Social History: Works at Woodhaven NH and cares for mentally disabled
• Smoking currently 1Pack per 2-3 days, restarted recently but never a heavy smoker
• Denied EtOH and illicit drug use.
• No known drug allergies
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 4
MEDICATIONS
• Atenolol for Hypertension
• Levothyroxine for Hypothyroidism
• Review of systems:
• Generalized weakness
• Hot flashes with regular menstrual cycles
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 5
PHYSICAL EXAMINATION
• Vital signs:
• Temperature: 36.8*C
• Heart rate: 79bpm
• Respiratory rate: 16 breaths/min
• Blood pressure: 151/96 mm of Hg
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 6
PHYSICAL EXAM CONTINUED…
• General: African-American female appears to be at stated age lying hunched over in hospital gown in
emergency department gurney with lights off and an ice pack on head. Answered questions with soft voice.
• HENT: normocephalic head. No tenderness over sinuses, mastoid region. No tenderness on Palpation
over the right scalp region and said it is helping her pain.
• Eye exam: bilateral proptosis, R>L with bilateral conjunctivae injection with no visible corneal, Iris, anterior
chamber lesions. No lid lag. No pallor or icterus noticed. Fundoscopic exam showed clear disc margins with
no signs of papilledema.
• Neck: No signs of rigidity or tenderness in the occipital groove. No carotid bruits. Transverse linear scar of
thyroidectomy in the lower portion of the neck.
• Cardiovascular: Regular rate and rhythm with no murmurs. Peripheral pulses are normal and equal.
• Respiratory: Clear to auscultation bilaterally
• Abdominal: soft, no tenderness, No visceromegaly
• Extremities: No cyanosis, clubbing or pedal edema.
• Skin: No rashes, pretibial myxedema
• Psychiatric: Normal affect and mood.
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 7
NEUROLOGICAL EXAM
• Higher mental functions: Alert, awake and oriented X 4, in mild distress from the
headache. Memory is intact to recent and remote memories as she is able to narrate her
family events and important dates in her life. Comprehension is intact. Speech is fluent
with no dysarthria.
• Cranial nerves:
• Optic Nerve: visual acuity is normal. Color vision is normal. Pupils 42mm with both
direct and consensual light reflex with no relative afferent pupillary defect.
• Occulomotor, Abducens and Trochlear: Extra ocular movements were intact except for
decreased abduction to the right side and associated with pain. Mild to moderate lid
retraction, No nystagmus.
• Trigeminal: No facial sensory loss. Jaw jerk is with in normal limits, Medial and lateral
pterygoids were strong.
• Facial: no facial asymmetry, orbicularis oculi is strong bilaterally, able to whistle
• Vestibulocochlear: No vertigo, hearing is normal to finger rub bilaterally
• Glossopharyngeal and Vagus: uvula is in midline and elevates symmetrically. Strong
voice.
• Spinal accessory: Shoulder shrug is 5/5 and sternocleidomastoids 5/5 bilaterally
• Hypoglossal: Tongue protrudes to midline with no atrophy
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 8
OPTHALMOLOGY FINDINGS
• Visual acuity 20/25- in right eye and 20/30+ in left eye, Mild to moderate proptosis, IOP is 14 in right eye and 13 in
left eye.
• Hertels: 25mm in the right eye and 23mm in the left eye.
• Ishihara color plates: 15/15 OU
• Mild lid retraction
• Sclera/Conjunctiva: 1-2+ injection OD>OS near muscle insertions
• Cornea: No edema, few scattered Superficial punctate keratitis OU, moderate dryness OU with decreased Tear
break up time
• Anterior chamber: Deep and quiet OU
• Lens: Clear OU
• Vitreous: Clear OU
• Fundus exam:
Disk: crisp margins 0.4C:D OU
Vessels: appear healthy : Macula: Flat and healthy OU : Peripheral : attached and healthy OU
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 9
Courtesy: Dr. Wilson from Ophthalmology.
NEUROLOGICAL EXAM CONTINUED…
• Motor system Exam: Bulk is equal bilaterally. Tone is with in normal limits in both the
flexors and extensors in bilateral upper and lower extremities.
• Strength is 5/5 in bilateral upper and lower extremities. No pronator drift.
• Reflexes: 2+/4 in bilateral biceps, brachioradialis, Knees and ankles. Plantars were down
going bilaterally.
• Sensory system examination: intact to light touch, pin prick and vibration in all the
extremities. Romberg’s sign is negative.
• Gait and Station: Normal
• Coordination: intact to finger to nose test bilaterally.
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 10
DIFFERENTIAL DIAGNOSIS
• Grave’s Opthalmopathy
• Retro orbital tumor/Hematoma
• Cavernous sinus thrombosis
• Migraine
• Vasculitis(Giant cell arteritis)
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 11
LABS
• CBC:
• Hb: 13g/dl
• HCT: 38.8%
• WBC: 6.2
• PLT: 328
• CMP:
• Na: 137
• K+: 2.7
• Cl: 92
• CO2: 31
• Glucose: 145
• BUN: 10
• Creatinine: 0.71
• Calcium: 6.1
• AST: 17; ALT: 17; ALP: 51
• TSH: 2.5
• Free T4: 1.29
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 12
LABS CONTINUED…
• Ionized calcium: 0.69(1.12-1.3)
• Magnesium: 1.6(1.7-2.3)
• 25 OH Vit-D: 54
• Intact PTH: 5 (ref: 15-65)
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 13
STRUCTURES IN ORBIT
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 14
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 15
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 16
RADIOLOGY
CT Head:
• Scattered hyperdense foci visualized in bilateral basal ganglia and subcortical white
matter of the bilateral occipital lobes and within cerebellum. Right rectus muscle is slightly
more prominent. Findings consistent with Fahr’s disease.
MRI of the Brain:
• Bilateral symmetrical calcification in bilateral basal ganglia, thalami, cerebellar dentate
nuclei suggestive of Fahr’s disease.
• Right sided proptosis with enlargement and increased enhancement of the inferior rectus
and medial rectus. Increased enhancement of the left superior oblique muscle. Primary
consideration is Thyroid orbitopathy / Pseudotumor / Myositis.
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 17
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 18
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 19
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 20
Diffuse calcifications involving all the basal ganglia
GRAVE’S OPTHALMOPATHY
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 21
• Incidence of 2.9-16.0 cases per 100,000 per year
• Female preponderance.
• Smoking increases the risk of developing thyroid eye disease by seven to eight fold.
• Anterior displacement of the globe by the edematous extra ocular muscles and orbital
fibro fatty tissues results in exophthalmos and lower lid retraction. These symptoms in
turn may lead to impaired lid closure and corneal ulceration, especially if the levator
muscle is also infiltrated and its excursion restricted.
• Edematous extra ocular muscles lose compliance, restrict eye movements, and can
compress the optic nerve at the orbital apex
• Common early symptoms include altered periocular appearance, symptoms related to the
eye surface (grittiness, photophobia, and excessive lacrimation), double vision, especially
at the extremes of gaze, and retro- orbital ache.
• Rundle’s curve is a fundamental concept in understanding and managing thyroid eye
disease, and it determines choice of treatment.
Pathophysiology of Grave’s opthalmopathy: Role of Orbital fibroblast
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 22
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 23
Atypical eye features requiring confirmation of the diagnosis of thyroid eye disease by
orbital imaging (CT or MRI)
• Unilateral disease
• Unilateral or bilateral disease in patients with no previous or present evidence of thyroid
dysfunction
• Absence of upper eyelid retraction
• Divergent strabismus
• Diplopia sole manifestation
• History of diplopia worsening towards the end of the day
Other ophthalmological conditions that can be misdiagnosed as thyroid eye disease
• Allergic conjunctivitis
• Myasthenia gravis
• Orbital myositis
• Chronic progressive external ophthalmoplegia
• Orbital tumors (primary or secondary)
• Carotid-cavernous fistula
• Any inflammatory orbitopathy (such as Wegener’s granulomatosis)
MANAGEMENT
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 24
• Once the diagnosis of thyroid eye disease is made, initial management consists of three
steps, in this order of priority:
• Ensuring that the patient has neither of the sight threatening eye complications: corneal
ulceration or optic neuropathy during which high dose IV Steroid pulse therapy salvages
the optic Neuropathy.
• Avoiding factors that exacerbate thyroid eye disease by introducing smoking cessation
strategies (if the patient is a smoker), correcting thyroid dysfunction, and protecting the
corneas with lubricants.
• Referring suitable patients to specialist centers based on European Group on Graves’
Orbitopathy (EUGOGO)
PREVENTION
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 25
• Smoking, uncontrolled thyroid dysfunction, and radioiodine therapy are risk factors for
development or exacerbation of thyroid eye disease.
• In the absence of clinical evidence of thyroid eye disease, radioiodine can be used safely
in patients with Graves’ disease. Expert advice should be sought before use of radioiodine
in patients with established thyroid eye disease. Passive smoking may be a risk factor for
development of thyroid eye disease in childhood.
Petros Perros, consultant endocrinologist1, Christopher Neoh, consultant ophthalmologist2, Jane Dickinson, consultant ophthalmologist2
1Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP 2Department of Ophthalmology, Royal Victoria Infirmary,
Newcastle upon Tyne NE1 4LP
FAHR’S DISEASE
• Fahr, a German pathologist from Hamburg, described in 1930 an 81-year-old patient with
a long history of dementia who presented to the hospital with fever and immobility and,
later, died. Examination of the brain revealed evidence of calcification in the striatum.
Although the description of bilateral basal ganglia calcification has previously been
described, Fahr's name has become associated with all forms of bilateral calcification in
the basal ganglia and other parts of the brain. Fahr's disease refers to idiopathic bilateral
calcification of the basal ganglia. These symmetrical calcifications of the strio-pallido-
dentate system are detectable in 0.7-1.2% of routine cerebral computed tomography (CT)-
scan and may be caused by different conditions. A review of the literature revealed that
one-third of patients with bilateral strio-pallido-dentate calcinosis (BSPDC) were clinically
asymptomatic, while the most common symptom was movement disorder.
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 26
My sincere thanks to
Dr. Shenker, MD, Ph.D
Dr. Shah, Syed, MD
Dr. Wilson, Phil, MD
Dr. Buzzola, Rino, MD
1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 27

More Related Content

What's hot

Case report: atypical Rathkes cleft cyst
Case report: atypical Rathkes cleft cystCase report: atypical Rathkes cleft cyst
Case report: atypical Rathkes cleft cyst
nhungnhikhoa
 

What's hot (20)

Neurological History Taking
Neurological History TakingNeurological History Taking
Neurological History Taking
 
Thunder
Thunder Thunder
Thunder
 
ORGANIC MENTAL DISORDERS
ORGANIC MENTAL DISORDERS ORGANIC MENTAL DISORDERS
ORGANIC MENTAL DISORDERS
 
ITP and SLE Clinical case presentation by Pamudith Karunaratne
ITP and SLE Clinical case presentation by Pamudith KarunaratneITP and SLE Clinical case presentation by Pamudith Karunaratne
ITP and SLE Clinical case presentation by Pamudith Karunaratne
 
Case presentation
Case presentation   Case presentation
Case presentation
 
Case presentation~cd874
Case presentation~cd874Case presentation~cd874
Case presentation~cd874
 
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and Treatment
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and TreatmentDr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and Treatment
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and Treatment
 
Headache
HeadacheHeadache
Headache
 
Case report: atypical Rathkes cleft cyst
Case report: atypical Rathkes cleft cystCase report: atypical Rathkes cleft cyst
Case report: atypical Rathkes cleft cyst
 
Headche
Headche  Headche
Headche
 
Primary headache
Primary headachePrimary headache
Primary headache
 
Ophthalmic Causes Of Headache
Ophthalmic Causes Of HeadacheOphthalmic Causes Of Headache
Ophthalmic Causes Of Headache
 
NEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTS
NEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTSNEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTS
NEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTS
 
Miller fisher syndrome
Miller fisher syndromeMiller fisher syndrome
Miller fisher syndrome
 
optic neuritis
optic neuritisoptic neuritis
optic neuritis
 
Friedreich ataxia case pres by dr adeel
Friedreich ataxia case pres by dr adeelFriedreich ataxia case pres by dr adeel
Friedreich ataxia case pres by dr adeel
 
Cns case presentation
Cns case presentationCns case presentation
Cns case presentation
 
Slide gross motordelayed gross motor
Slide gross motordelayed gross motorSlide gross motordelayed gross motor
Slide gross motordelayed gross motor
 
Approach to patient with headache
Approach to patient with headacheApproach to patient with headache
Approach to patient with headache
 
Headache; A Clinical Approach
Headache; A Clinical Approach Headache; A Clinical Approach
Headache; A Clinical Approach
 

Similar to Grave's Opthalmopathy

Tuberculous meningitis
Tuberculous meningitisTuberculous meningitis
Tuberculous meningitis
arnab ghosh
 
a-Case-of-Refractory-Epilepsy.pptx
a-Case-of-Refractory-Epilepsy.pptxa-Case-of-Refractory-Epilepsy.pptx
a-Case-of-Refractory-Epilepsy.pptx
aartichande
 

Similar to Grave's Opthalmopathy (20)

CLINICOPATHOLOGICAL CONFERENCE ON Thyroid eye disease
CLINICOPATHOLOGICAL CONFERENCE ON Thyroid eye diseaseCLINICOPATHOLOGICAL CONFERENCE ON Thyroid eye disease
CLINICOPATHOLOGICAL CONFERENCE ON Thyroid eye disease
 
Neuromyelitis Optica
Neuromyelitis OpticaNeuromyelitis Optica
Neuromyelitis Optica
 
Vogt Koyanagi Harada Syndrome (VKH)
Vogt Koyanagi Harada Syndrome (VKH)Vogt Koyanagi Harada Syndrome (VKH)
Vogt Koyanagi Harada Syndrome (VKH)
 
IM 2.pptx
IM 2.pptxIM 2.pptx
IM 2.pptx
 
Tuberculous meningitis
Tuberculous meningitisTuberculous meningitis
Tuberculous meningitis
 
Multiple cranial nerve palsies
Multiple cranial nerve palsiesMultiple cranial nerve palsies
Multiple cranial nerve palsies
 
Mohamed Osman.pptx
Mohamed Osman.pptxMohamed Osman.pptx
Mohamed Osman.pptx
 
FAROOQ KHAN moya moya
FAROOQ KHAN moya moyaFAROOQ KHAN moya moya
FAROOQ KHAN moya moya
 
Cerebral Venous Sinus Thrombosis (CVST) Case Report
Cerebral Venous Sinus Thrombosis (CVST) Case ReportCerebral Venous Sinus Thrombosis (CVST) Case Report
Cerebral Venous Sinus Thrombosis (CVST) Case Report
 
GWR LE panuveitis.pptx
GWR LE panuveitis.pptxGWR LE panuveitis.pptx
GWR LE panuveitis.pptx
 
OSCE MAY 2022-PART-4 -PAED.pptx
OSCE MAY 2022-PART-4 -PAED.pptxOSCE MAY 2022-PART-4 -PAED.pptx
OSCE MAY 2022-PART-4 -PAED.pptx
 
Atypical presentation of Tubercular meningitis
Atypical presentation of Tubercular meningitisAtypical presentation of Tubercular meningitis
Atypical presentation of Tubercular meningitis
 
Retina Rounds
Retina RoundsRetina Rounds
Retina Rounds
 
approach to a child with altered sensorium.pptx
approach to a child with altered sensorium.pptxapproach to a child with altered sensorium.pptx
approach to a child with altered sensorium.pptx
 
Multiple sclerosis 2015
Multiple sclerosis 2015 Multiple sclerosis 2015
Multiple sclerosis 2015
 
a-Case-of-Refractory-Epilepsy.pptx
a-Case-of-Refractory-Epilepsy.pptxa-Case-of-Refractory-Epilepsy.pptx
a-Case-of-Refractory-Epilepsy.pptx
 
A Case of TOLOSA HUNT SYNDROME
A Case of TOLOSA HUNT SYNDROMEA Case of TOLOSA HUNT SYNDROME
A Case of TOLOSA HUNT SYNDROME
 
TOLOSA HUNT SYNDROME
TOLOSA HUNT SYNDROMETOLOSA HUNT SYNDROME
TOLOSA HUNT SYNDROME
 
Pediatric Community Acquired Pneumonia
Pediatric Community Acquired PneumoniaPediatric Community Acquired Pneumonia
Pediatric Community Acquired Pneumonia
 
Tb.pptx
Tb.pptxTb.pptx
Tb.pptx
 

More from Prisma Health Upstate

More from Prisma Health Upstate (20)

Cerebral gas embolism
Cerebral gas embolismCerebral gas embolism
Cerebral gas embolism
 
Pharmacological management of cerebral vasospasm in subarachnoid hemorrhage
Pharmacological management of cerebral vasospasm in subarachnoid hemorrhagePharmacological management of cerebral vasospasm in subarachnoid hemorrhage
Pharmacological management of cerebral vasospasm in subarachnoid hemorrhage
 
Decompressive hemicraniectomy for Large Hemispheric infarction
Decompressive hemicraniectomy for Large Hemispheric infarctionDecompressive hemicraniectomy for Large Hemispheric infarction
Decompressive hemicraniectomy for Large Hemispheric infarction
 
Patent foramen ovale management in cryptogenic stroke
Patent foramen ovale management in cryptogenic strokePatent foramen ovale management in cryptogenic stroke
Patent foramen ovale management in cryptogenic stroke
 
Stroke a clinical talk
Stroke   a clinical talkStroke   a clinical talk
Stroke a clinical talk
 
Tenecteplase : A better tPA for Acute ischemic stroke?
Tenecteplase : A better tPA for Acute ischemic stroke?Tenecteplase : A better tPA for Acute ischemic stroke?
Tenecteplase : A better tPA for Acute ischemic stroke?
 
Cerebrovascular anatomy
Cerebrovascular anatomyCerebrovascular anatomy
Cerebrovascular anatomy
 
Acute Stroke management
Acute Stroke managementAcute Stroke management
Acute Stroke management
 
Immune mediated neuropathies
Immune mediated neuropathiesImmune mediated neuropathies
Immune mediated neuropathies
 
Olfactory and optic nerve
Olfactory and optic nerveOlfactory and optic nerve
Olfactory and optic nerve
 
Pediatric stroke
Pediatric strokePediatric stroke
Pediatric stroke
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous system
 
Reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndrome
 
Wernekink commissure syndrome
Wernekink commissure syndromeWernekink commissure syndrome
Wernekink commissure syndrome
 
Frontal lobe epilepsy
Frontal lobe epilepsyFrontal lobe epilepsy
Frontal lobe epilepsy
 
Motor tracts
Motor tractsMotor tracts
Motor tracts
 
An Update on Blood Biomarkers for Stroke
An Update on Blood Biomarkers for StrokeAn Update on Blood Biomarkers for Stroke
An Update on Blood Biomarkers for Stroke
 
A Review on Neurosarcoidosis Dec 21, 2016
A Review on Neurosarcoidosis Dec 21, 2016A Review on Neurosarcoidosis Dec 21, 2016
A Review on Neurosarcoidosis Dec 21, 2016
 
Leptomeningeal Enhancement
Leptomeningeal EnhancementLeptomeningeal Enhancement
Leptomeningeal Enhancement
 
Whiteout disease
Whiteout diseaseWhiteout disease
Whiteout disease
 

Grave's Opthalmopathy

  • 3. HISTORY OF PRESENT ILLNESS • Chief complaint: New onset headache for 5 days • History of present illness: 48 year old African American female with history of Hypothyroidism and Hypertension otherwise in good health presented to the university ER with the new onset headache for the past 5 days which is located on the Right temporal region and was about 10/10 in intensity, started slowly and gradually progressed. Pain is throbbing with occasional sharp character over the right temple with no radiation. Sleep and IBUPROFEN make the pain better and looking towards the right makes the pain worse. No changes with position, coughing or bearing down, diurnal variations or with chewing. The headache is also associated with light sensitivity and occasional sonophobia, Kinesophobia. She also complained of double vision when looking to the right side associated with pain with the false image on the outer side of the original image. Her eyes have been red, right-sided greater than left side since the same day when the headache started initially. Complained of gritty sensation, dryness. Negative history: she denied any fever, chills, neck stiffness, passing out spells, lateralized weakness or numbness. Denied any stress. No fatigue, dizziness, lightheadedness, loss of appetite, weight or recent weight gain. No recent URI symptoms or dental infections. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 3
  • 4. HISTORY CONTINUED… • PMH/PSH: Hypertension, Hypothyroidism S/p Thyroidectomy in 1981 for Grave’s Disease • Family History: Father had MI and died of Stroke • Paternal grandfather with Seizure, No family history of Migraines or AVMs • Strong family history of Grave’s disease with affected Grand Mother, Mother and three sisters • Social History: Works at Woodhaven NH and cares for mentally disabled • Smoking currently 1Pack per 2-3 days, restarted recently but never a heavy smoker • Denied EtOH and illicit drug use. • No known drug allergies 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 4
  • 5. MEDICATIONS • Atenolol for Hypertension • Levothyroxine for Hypothyroidism • Review of systems: • Generalized weakness • Hot flashes with regular menstrual cycles 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 5
  • 6. PHYSICAL EXAMINATION • Vital signs: • Temperature: 36.8*C • Heart rate: 79bpm • Respiratory rate: 16 breaths/min • Blood pressure: 151/96 mm of Hg 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 6
  • 7. PHYSICAL EXAM CONTINUED… • General: African-American female appears to be at stated age lying hunched over in hospital gown in emergency department gurney with lights off and an ice pack on head. Answered questions with soft voice. • HENT: normocephalic head. No tenderness over sinuses, mastoid region. No tenderness on Palpation over the right scalp region and said it is helping her pain. • Eye exam: bilateral proptosis, R>L with bilateral conjunctivae injection with no visible corneal, Iris, anterior chamber lesions. No lid lag. No pallor or icterus noticed. Fundoscopic exam showed clear disc margins with no signs of papilledema. • Neck: No signs of rigidity or tenderness in the occipital groove. No carotid bruits. Transverse linear scar of thyroidectomy in the lower portion of the neck. • Cardiovascular: Regular rate and rhythm with no murmurs. Peripheral pulses are normal and equal. • Respiratory: Clear to auscultation bilaterally • Abdominal: soft, no tenderness, No visceromegaly • Extremities: No cyanosis, clubbing or pedal edema. • Skin: No rashes, pretibial myxedema • Psychiatric: Normal affect and mood. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 7
  • 8. NEUROLOGICAL EXAM • Higher mental functions: Alert, awake and oriented X 4, in mild distress from the headache. Memory is intact to recent and remote memories as she is able to narrate her family events and important dates in her life. Comprehension is intact. Speech is fluent with no dysarthria. • Cranial nerves: • Optic Nerve: visual acuity is normal. Color vision is normal. Pupils 42mm with both direct and consensual light reflex with no relative afferent pupillary defect. • Occulomotor, Abducens and Trochlear: Extra ocular movements were intact except for decreased abduction to the right side and associated with pain. Mild to moderate lid retraction, No nystagmus. • Trigeminal: No facial sensory loss. Jaw jerk is with in normal limits, Medial and lateral pterygoids were strong. • Facial: no facial asymmetry, orbicularis oculi is strong bilaterally, able to whistle • Vestibulocochlear: No vertigo, hearing is normal to finger rub bilaterally • Glossopharyngeal and Vagus: uvula is in midline and elevates symmetrically. Strong voice. • Spinal accessory: Shoulder shrug is 5/5 and sternocleidomastoids 5/5 bilaterally • Hypoglossal: Tongue protrudes to midline with no atrophy 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 8
  • 9. OPTHALMOLOGY FINDINGS • Visual acuity 20/25- in right eye and 20/30+ in left eye, Mild to moderate proptosis, IOP is 14 in right eye and 13 in left eye. • Hertels: 25mm in the right eye and 23mm in the left eye. • Ishihara color plates: 15/15 OU • Mild lid retraction • Sclera/Conjunctiva: 1-2+ injection OD>OS near muscle insertions • Cornea: No edema, few scattered Superficial punctate keratitis OU, moderate dryness OU with decreased Tear break up time • Anterior chamber: Deep and quiet OU • Lens: Clear OU • Vitreous: Clear OU • Fundus exam: Disk: crisp margins 0.4C:D OU Vessels: appear healthy : Macula: Flat and healthy OU : Peripheral : attached and healthy OU 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 9 Courtesy: Dr. Wilson from Ophthalmology.
  • 10. NEUROLOGICAL EXAM CONTINUED… • Motor system Exam: Bulk is equal bilaterally. Tone is with in normal limits in both the flexors and extensors in bilateral upper and lower extremities. • Strength is 5/5 in bilateral upper and lower extremities. No pronator drift. • Reflexes: 2+/4 in bilateral biceps, brachioradialis, Knees and ankles. Plantars were down going bilaterally. • Sensory system examination: intact to light touch, pin prick and vibration in all the extremities. Romberg’s sign is negative. • Gait and Station: Normal • Coordination: intact to finger to nose test bilaterally. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 10
  • 11. DIFFERENTIAL DIAGNOSIS • Grave’s Opthalmopathy • Retro orbital tumor/Hematoma • Cavernous sinus thrombosis • Migraine • Vasculitis(Giant cell arteritis) 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 11
  • 12. LABS • CBC: • Hb: 13g/dl • HCT: 38.8% • WBC: 6.2 • PLT: 328 • CMP: • Na: 137 • K+: 2.7 • Cl: 92 • CO2: 31 • Glucose: 145 • BUN: 10 • Creatinine: 0.71 • Calcium: 6.1 • AST: 17; ALT: 17; ALP: 51 • TSH: 2.5 • Free T4: 1.29 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 12
  • 13. LABS CONTINUED… • Ionized calcium: 0.69(1.12-1.3) • Magnesium: 1.6(1.7-2.3) • 25 OH Vit-D: 54 • Intact PTH: 5 (ref: 15-65) 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 13
  • 14. STRUCTURES IN ORBIT 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 14
  • 17. RADIOLOGY CT Head: • Scattered hyperdense foci visualized in bilateral basal ganglia and subcortical white matter of the bilateral occipital lobes and within cerebellum. Right rectus muscle is slightly more prominent. Findings consistent with Fahr’s disease. MRI of the Brain: • Bilateral symmetrical calcification in bilateral basal ganglia, thalami, cerebellar dentate nuclei suggestive of Fahr’s disease. • Right sided proptosis with enlargement and increased enhancement of the inferior rectus and medial rectus. Increased enhancement of the left superior oblique muscle. Primary consideration is Thyroid orbitopathy / Pseudotumor / Myositis. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 17
  • 20. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 20 Diffuse calcifications involving all the basal ganglia
  • 21. GRAVE’S OPTHALMOPATHY 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 21 • Incidence of 2.9-16.0 cases per 100,000 per year • Female preponderance. • Smoking increases the risk of developing thyroid eye disease by seven to eight fold. • Anterior displacement of the globe by the edematous extra ocular muscles and orbital fibro fatty tissues results in exophthalmos and lower lid retraction. These symptoms in turn may lead to impaired lid closure and corneal ulceration, especially if the levator muscle is also infiltrated and its excursion restricted. • Edematous extra ocular muscles lose compliance, restrict eye movements, and can compress the optic nerve at the orbital apex • Common early symptoms include altered periocular appearance, symptoms related to the eye surface (grittiness, photophobia, and excessive lacrimation), double vision, especially at the extremes of gaze, and retro- orbital ache. • Rundle’s curve is a fundamental concept in understanding and managing thyroid eye disease, and it determines choice of treatment.
  • 22. Pathophysiology of Grave’s opthalmopathy: Role of Orbital fibroblast 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 22
  • 23. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 23 Atypical eye features requiring confirmation of the diagnosis of thyroid eye disease by orbital imaging (CT or MRI) • Unilateral disease • Unilateral or bilateral disease in patients with no previous or present evidence of thyroid dysfunction • Absence of upper eyelid retraction • Divergent strabismus • Diplopia sole manifestation • History of diplopia worsening towards the end of the day Other ophthalmological conditions that can be misdiagnosed as thyroid eye disease • Allergic conjunctivitis • Myasthenia gravis • Orbital myositis • Chronic progressive external ophthalmoplegia • Orbital tumors (primary or secondary) • Carotid-cavernous fistula • Any inflammatory orbitopathy (such as Wegener’s granulomatosis)
  • 24. MANAGEMENT 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 24 • Once the diagnosis of thyroid eye disease is made, initial management consists of three steps, in this order of priority: • Ensuring that the patient has neither of the sight threatening eye complications: corneal ulceration or optic neuropathy during which high dose IV Steroid pulse therapy salvages the optic Neuropathy. • Avoiding factors that exacerbate thyroid eye disease by introducing smoking cessation strategies (if the patient is a smoker), correcting thyroid dysfunction, and protecting the corneas with lubricants. • Referring suitable patients to specialist centers based on European Group on Graves’ Orbitopathy (EUGOGO)
  • 25. PREVENTION 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 25 • Smoking, uncontrolled thyroid dysfunction, and radioiodine therapy are risk factors for development or exacerbation of thyroid eye disease. • In the absence of clinical evidence of thyroid eye disease, radioiodine can be used safely in patients with Graves’ disease. Expert advice should be sought before use of radioiodine in patients with established thyroid eye disease. Passive smoking may be a risk factor for development of thyroid eye disease in childhood. Petros Perros, consultant endocrinologist1, Christopher Neoh, consultant ophthalmologist2, Jane Dickinson, consultant ophthalmologist2 1Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP 2Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
  • 26. FAHR’S DISEASE • Fahr, a German pathologist from Hamburg, described in 1930 an 81-year-old patient with a long history of dementia who presented to the hospital with fever and immobility and, later, died. Examination of the brain revealed evidence of calcification in the striatum. Although the description of bilateral basal ganglia calcification has previously been described, Fahr's name has become associated with all forms of bilateral calcification in the basal ganglia and other parts of the brain. Fahr's disease refers to idiopathic bilateral calcification of the basal ganglia. These symmetrical calcifications of the strio-pallido- dentate system are detectable in 0.7-1.2% of routine cerebral computed tomography (CT)- scan and may be caused by different conditions. A review of the literature revealed that one-third of patients with bilateral strio-pallido-dentate calcinosis (BSPDC) were clinically asymptomatic, while the most common symptom was movement disorder. 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 26
  • 27. My sincere thanks to Dr. Shenker, MD, Ph.D Dr. Shah, Syed, MD Dr. Wilson, Phil, MD Dr. Buzzola, Rino, MD 1/10/2016UNIVERSITY OF MISSOURI HEALTHCARE 27